AI Portfolio Summary
In 2025 Q4, PFIZER INC maintained a portfolio of 21 distinct positions. Conversely, PFIZER INC completely exited their position in ESSA PHARMA INC.
Total Positions
21
Quarter
2025 Q4
Top Holding
ORIC (18.6%)
Top 10 Concentration
95.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 18.60% | 14.75% |
#1
1
Prev: #2
|
7.0 | no change | no change |
P
S
|
5,376,344 | $43,978,494 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARVN
ARVINAS INC
|
Healthcare | 17.34% | 6.73% |
#2
2
Prev: #4
|
6.5 | no change | no change |
P
S
|
3,457,815 | $41,009,686 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 14.74% | 3.95% |
#3
3
Prev: #6
|
6.0 | no change | no change |
P
S
|
349,406 | $34,849,754 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 13.48% | 3.14% |
#4
4
Prev: #8
|
5.5 | no change | no change |
P
S
|
1,875,000 | $31,875,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 12.76% | 6.25% |
#5
Prev: #5
|
5.5 | no change | no change |
P
S
|
22,032,040 | $30,183,895 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 6.58% | 2.94% |
#6
3
Prev: #9
|
3.6 | no change | no change |
P
S
|
2,970,022 | $15,562,915 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 3.42% | 3.57% |
#7
Prev: #7
|
2.4 | no change | no change |
P
S
|
7,032,770 | $8,087,685 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBU
CARIBOU BIOSCIE...
|
Healthcare | 3.15% | 2.50% |
#8
2
Prev: #10
|
2.3 | no change | no change |
P
S
|
4,690,431 | $7,457,785 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRDF
CARDIFF ONCOLOG...
|
Healthcare | 2.87% | 1.14% |
#9
3
Prev: #12
|
2.1 | no change | no change |
P
S
|
2,411,575 | $6,776,526 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 2.41% | 1.73% |
#10
1
Prev: #11
|
2.0 | no change | no change |
P
S
|
505,645 | $5,708,732 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 2.33% | 1.02% |
#11
2
Prev: #13
|
1.9 | no change | no change |
P
S
|
2,362,348 | $5,504,271 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.95% | 0.21% |
#12
3
Prev: #15
|
1.4 | no change | no change |
P
S
|
157,646 | $2,236,997 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 0.54% | 0.33% |
#13
1
Prev: #14
|
1.2 | no change | no change |
P
S
|
953,834 | $1,287,675 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.39% | 0.13% |
#14
3
Prev: #17
|
1.2 | no change | no change |
P
S
|
277,777 | $922,220 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.34% | 0.21% |
#15
1
Prev: #16
|
1.1 | no change | no change |
P
S
|
715,295 | $815,436 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.07% | 0.04% |
#16
3
Prev: #19
|
1.0 | no change | no change |
P
S
|
31,305 | $171,176 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 0.01% | 0.01% |
#17
3
Prev: #20
|
1.0 | no change | no change |
P
S
|
2,928 | $24,332 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 0.01% | 0.00% |
#18
3
Prev: #21
|
0.0 | -41,255 | -95.0% |
P
S
|
2,171 | $11,983 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EPIX
ESSA PHARMA INC
|
Unknown | 0.00% | 0.07% |
Sold All 😨
(Was: #18) |
0.0 | -1,675,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRML
TOURMALINE BIO ...
|
Unknown | 0.00% | 13.91% |
Sold All 😨
(Was: #3) |
0.0 | -1,272,214 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BNTX
BIONTECH SE
|
Healthcare | 0.00% | 37.39% |
Sold All 😨
(Was: #1) |
0.0 | -1,658,361 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-21 of 21 holdings